ICCM (IceCure Medical) חוב כולל להון

The market valuation dynamics for IceCure Medical Ltd (ICCM) based on the total debt-to-equity ratio is 0.01. IceCure Medical Ltd is developing a closed cryotherapy ecosystem where the combination of unique cooling systems and consumables locks clinics into a specific provider. A positive trend in minimally invasive tumor treatment provides crisis resilience, although the business's Israeli origin creates risks due to local wars and export restrictions.

This ratio determines the proportion of borrowed funds relative to equity, measuring the degree of financial leverage and the business's dependence on external creditors. For IceCure Medical (ICCM), which invests in highly qualified biomedical specialists and the development of cryoablation, a leverage balance is critical for sustaining technological growth; therefore, analyzing the IceCure Medical (ICCM) financial leverage chart allows for an assessment of the stability of its innovation strategy.